Analyst firms · HSBC · AZN
HSBC AZN price target and rating history
AstraZeneca PLC (AZN) · Health Care
HSBC rates AstraZeneca PLC (AZN) Hold with a $78 price target, as of its latest action on Jul 13, 2026. It has published 3 rating actions on AZN since July 2023, including 0 upgrades and 1 downgrade.
- Current rating
- Hold
- Price target
- $78
- Median target, all firms
- Too few
- Actions on AZN
- 3
Every HSBC rating on AZN
- Jul 13, 2026DowngradeHSBC downgrades to Hold from Buy
- Dec 18, 2023
- Jul 14, 2023InitiateHSBC starts coverage at Buy
How other firms rate AZN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Hold | Sep 15, 2026 | |
| RBC Capital Markets | Outperform | Sep 9, 2026 | |
| HSBC | Hold | Jul 13, 2026 | |
| Citigroup | Buy | Jan 27, 2026 |
Questions about HSBC and AZN
- What is HSBC's price target for AZN?
- HSBC's latest stated price target for AstraZeneca PLC (AZN) is $78, from its action on Dec 18, 2023.
- What is HSBC's rating on AZN?
- HSBC rates AZN Hold, a neutral rating, as of Jul 13, 2026.
- When did HSBC last change its view on AZN?
- On Jul 13, 2026, HSBC downgrades to Hold from Buy.
More AZN rating histories
All HSBC ratingsAZN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.